T细胞治疗解决方案,简化从发现到治愈的探索之旅 Cell Therapy Manufacturing 将干细胞治疗从研究领域推广到临床及其他领域 随着干细胞治疗的发展,人们了解到干细胞可用于细胞替代疗法、免疫调节疗法等各种临床应用。无论您是开发诱导性多能干细胞治疗还是成体干细胞治疗,赛默飞世尔科技都能提供解决方案,将您的研究推进...
Cell Therapy Manufacturing 基因治疗解决方案 发现细胞和基因治疗产品和解决方案 生产解决方案 细胞和基因治疗定制服务 细胞与基因治疗实验室设备 我们提供全流程解决方案,在每个阶段为您的细胞治疗开发提供支持。我们的目标是:通过优质的材料和服务,支持您每个阶段(从最初的发现到临床试验、再到商业上可行的细胞...
Discover closed, scalable cell processing and electroporation systems for your GMP iPSC research and manufacturing 新! Gibco™ CTS™ Rotea™逆流离心系统-用于细胞治疗生产的封闭式细胞处理系统 多功能Gibco™ CTS™ Rotea™逆流离心系统是一种高度通用的系统,具有出色的灵活性。系统内置用户可编程的软...
Episode 3: Impact of raw materials on cell therapy development Raw material selection is key for cell therapy manufacturing endeavors, as it can impact cost, process, quality, and reproducibility. Hear comments on this topic from representatives from ViaCyte, Inc and City of Hope. ...
目前,细胞治疗研究(cellular therapy research)利用某些具有特定功能细胞的特性,采用生物工程方法获取或/和通过体外扩增、特殊培养等处理后,使这些细胞具有增强免疫、杀灭病原体和肿瘤细胞、促进组织器官再生和机体康复等治疗功效,从而达到治疗疾病的目的,目前已不同适应症为对象的细胞治疗研究项目已经开展的如火如荼。
Thermo Fisher Scientific announced the completion of Henogen SA, Groupe Novasep SAS’s viral vector manufacturing business in Belgium. The deal was for €725 million in cash.
细胞因子用于维持免疫细胞培养以及激活和分化,直到至其期望的表型。使用重组细胞因子和生长因子有助于优化体外免疫细胞功能,并有助于成功完成的免疫细胞培养。GibcoPeproTech 重组细胞因子的设计和制造旨在帮助您实现细胞培养条件的标准化,并获得可靠的免疫学研究结果。
细胞因子用于维持免疫细胞培养以及激活和分化,直到至其期望的表型。使用重组细胞因子和生长因子有助于优化体外免疫细胞功能,并有助于成功完成的免疫细胞培养。GibcoPeproTech 重组细胞因子的设计和制造旨在帮助您实现细胞培养条件的标准化,并获得可靠的免疫学研究结果。
"The cell therapy industry is expanding steadily, and Thermo Fisher Scientific is committed to empowering developers to accelerate the time between R&D to full-scale manufacturing and commercialization," saidAmy Butler, vice president and general manager of cell biology at Thermo Fisher Scientific. "Th...
Strengthened our unique customer value proposition with the opening of a new biorepository in Vacaville, California, to advance our cell and gene therapy services. We also brought additional bioproduction capacity online for single-use containers and cell cul...